Latest Articles
- ArticleNatalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II allelesBelén de la Hera, Elena Urcelay, David Brassat, et al.December 11, 2014
- ArticleLeucine-rich glioma-inactivated protein 1 antibody encephalitisA case reportYunis Mayasi, Deepak Takhtani, Neeta GargDecember 11, 2014
- ArticleOccurrence of hemolytic anemia in patients with GBS treated with high-dose IVIgThy P. Nguyen, Suur Biliciler, Amer Wahed, et al.December 11, 2014
- EditorialThe genetics of natalizumab hypersensitivityOne learns to itch where one can scratchOlaf Stüve, Bernhard HemmerDecember 11, 2014
- ArticleRituximab as a first-line preventive treatment in pediatric NMOSDsPreliminary results in 5 childrenGiulia Longoni, Brenda Banwell, Massimo Filippi, et al.December 11, 2014
- ArticleCB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosisFrancesco Mori, Concetta Ljoka, Carolina G. Nicoletti, et al.December 11, 2014
- Clinical/Scientific NotesVogt-Koyanagi-Harada syndrome: A novel case and brief review of focal neurologic presentationsFaheem Sheriff, Nandakumar S. Narayanan, Anita J. Huttner, et al.November 20, 2014
- Views & ReviewsNonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosisAna C. Londoño, Carlos A. MoraNovember 20, 2014
- Clinical/Scientific NotesLeptomeningeal inflammation in rheumatoid arthritisSimona Lattanzi, Claudia Cagnetti, Paolo Di Bella, et al.November 20, 2014
Pages
Advertisement
Dr. Nicole Sur and Dr. Mausaminben Hathidara